Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Dextrose is also called as glucose, as they are chemically identical. It plays a vital role in providing energy to body cells. Dextrose injection is a non-pyrogenic and sterile solution for caloric supply and fluid replenishment by a single dose. Route of administration of dextrose injection is intravenous i.e. into the vein. Dosage of dextrose injection depends upon the weight, age, and clinical condition of the patient. Dextrose 5% in water is injected into the vein to replace lost fluids and it also provides carbohydrates to the body. Dextrose 5% in water is also used to treat hypoglycemia (low blood sugar), insulin shock, and dehydration (fluid loss). Dextrose is a carbohydrate, which is a part of nutrition. Dextrose solution along with amino acids and fats provide nutrition to the body. This is called as total parental nutrition. Dextrose solution (50%) is administered to people suffering from hyperkalemia, which is a condition in which potassium levels are high.

The global dextrose injection market is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% over the forecast period (2020-2027).

Figure 1. Global Dextrose Injection Market Share (%) in Terms of Value, By Region, 2020

Dextrose Injection  | Coherent Market Insights

Increasing incidence of diabetes and conditions associated with diabetes such as hypoglycemia is expected to drive the market growth over the forecast period 

According to the World Health Organization report published in June 2020, globally, the number of people with diabetes rose from 108 million in 1980 to 422 million in 2014.

Moreover, hypoglycemia is a condition in which blood sugar (glucose) level is lower than normal. Hypoglycemia is often related to diabetes treatment. According to a survey conducted by the Centers for Disease Control and Prevention (CDC), in 2016, more than 1.5 million people in the U.S. suffered from hypoglycemia.

Furthermore, various sports initiatives taken by the Indian government for the promotion of sports among individuals suffering from disabilities. ‘Khelo India’, National Sports Development Fund Scheme for promotion of sports among individuals suffering from disabilities. According to Khelo India Program, 1,000 students are selected annually and offered a sponsorship of 5 lakhs for 8 years. Such huge participation in sports is expected to boost growth of the global dextrose injection market. Athletes use dextrose injection to treat a variety of ligament, muscle, tendon, and joint pain.

Figure 2. Global Dextrose Injection Market Share (%), by Product Type, 2020

Dextrose Injection  | Coherent Market Insights

Increasing launch and approval of products is expected to drive the market growth over the forecast period

Key players operating in the market are focusing on novel product launches and approvals, in order to expand their product portfolio and increase presence in the global market.

For instance, in July 2020, Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, launched Dacarbazine for Injection with dextrose solution for the treatment of metastatic malignant melanoma. The reconstituted solution may be further diluted with 5% dextrose injection or sodium chloride injection, and administered as an intravenous infusion.

In April 2018, SteriMAx Inc., company engaged in the production, development, marketing, and distribution of essential hospital and retail pharmacy products, launched a new drug Bupivacaine Hydrochloride in 8.25% dextrose injection indicated for spinal anesthesia. It is a subarachnoid injection (spinal block).

For instance, in 2017, Clindamycin in dextrose injection (D5W) made by Water Street Healthcare Partners, a private equity firm, which focuses extensively on building market leading companies in healthcare and Celerity Pharmaceuticals LLC, which provides drug development services, was approved by the U.S. Food and Drug Administration. Clindamycin in dextrose injection (D5W) is used to treat bacterial infections such as pneumonia by inhibiting growth of bacteria in the body.

request-sample

Dextrose Injection Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 9,512.7 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.7% 2027 Value Projection: US$ 14,056.6 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: 5% Dextrose Injection, 10% Dextrose Injection, 50% Dextrose Injection, 70% Dextrose Injection, Others.
  • By Application: First-aid Treatment, Sports, Trophotherapy, Others.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
Companies covered:

Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.

Growth Drivers:
  • Increasing incidence of diabetes and conditions associated with diabetes such as hypoglycemia
  • Increasing launch and approval of products
  • Rising government initiatives for the promotion of sports among individuals suffering from disabilities
Restraints & Challenges:
  • Side effects caused by dextrose injection
  • Product recall

Global Dextrose Injection Market – Impact of Coronavirus (Covid-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) resulted in more than 31 million infected individuals worldwide as of  September 21, 2020. Furthermore, key players operating in the market are focusing on novel product launch in order to combat COVID -19. For instance, in May 2020, Hikma Pharmaceuticals PLC (Hikma, Group), a multinational pharmaceutical company, announced the launch of Propofol Injectable Emulsion, USP, 20 mL, 50 mL, and 100 mL vials with 5% dextrose injection, in the U.S. through its US affiliate, Hikma Pharmaceuticals USA Inc. Propofol injectable emulsion is provided as a ready-to-use formulation. However, should dilution be necessary, it should only be diluted with 5% Dextrose Injection, USP and it should not be diluted to a concentration less than 2 mg/mL because it is an emulsion.

Propofol Injectable Emulsion is indicated for the maintenance of sedation and anesthesia for intubated, mechanically ventilated adults in the intensive care unit. It is currently on the FDA's Drug Shortage List, following a surge in demand due to the increase in hospitalized, ventilated patients due to the COVID-19 pandemic.

Global Dextrose Injection Market - Restraint

Side effects caused by dextrose injection such as fever, infection at the site of injection, and blood clot at the site of injection, and voluntary product recall are major factors restraining growth of the dextrose injection market.

For instance, in February 2018, the U.S. Food and Drug Administration announced the recall of Hospira, Inc., a Pfizer company’s, one lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.

Key Players

Major players operating in the global dextrose injection market include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.

Dextrose injection contain source of water and calories, and is capable of inducing diuresis depending on the clinical condition of the patient. Dextrose injections are sterile, non-pyrogenic, and does not contain bacteriostatic or antimicrobial agents. It is intended for intravenous administration. This intravenous solution is indicated for use in adults and pediatric patients as sources of calories and water for hydration. Dosage of dextrose injection is dependent upon the age, weight, and clinical condition of the patient as well as laboratory determinations.

Market Dynamics

Increasing launches and approval of novel products, increasing adoption of inorganic growth strategies such as collaboration and acquisition by key players operating in the market and rising demand for dextrose for first-aid treatment as instant nutrition therapy in critical care are expected to drive the growth of global dextrose injection market over the forecast period. For instance, in July 2015, B. Braun Medical Inc. received the U.S. Food and Drug Administration approval for 70% Dextrose for Injection in a 2L flexible container.

Key features of the study:

  • This report provides in-depth analysis of the global dextrose injection market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global dextrose injection market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global dextrose injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dextrose injection market

Detailed Segmentation:

  • Global Dextrose Injection Market, By Product Type:
    • 5% Dextrose Injection
    • 10% Dextrose Injection
    • 50% Dextrose Injection
    • 70% Dextrose Injection
    • Others
  • Global Dextrose Injection Market, By Application:
    • First-aid Treatment
    • Sports
    • Trophotherapy
    • Others
  • Global Dextrose Injection Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Dextrose Injection Market, By Region:
    • North America
      • By Product Type:
        • 5% Dextrose Injection
        • 10% Dextrose Injection
        • 50% Dextrose Injection
        • 70% Dextrose Injection
        • Others
      • By Application:
        • First-aid Treatment
        • Sports
        • Trophotherapy
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • 5% Dextrose Injection
        • 10% Dextrose Injection
        • 50% Dextrose Injection
        • 70% Dextrose Injection
        • Others
      • By Application:
        • First-aid Treatment
        • Sports
        • Trophotherapy
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • 5% Dextrose Injection
        • 10% Dextrose Injection
        • 50% Dextrose Injection
        • 70% Dextrose Injection
        • Others
      • By Application:
        • First-aid Treatment
        • Sports
        • Trophotherapy
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • 5% Dextrose Injection
        • 10% Dextrose Injection
        • 50% Dextrose Injection
        • 70% Dextrose Injection
        • Others
      • By Application:
        • First-aid Treatment
        • Sports
        • Trophotherapy
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • 5% Dextrose Injection
        • 10% Dextrose Injection
        • 50% Dextrose Injection
        • 70% Dextrose Injection
        • Others
      • By Application:
        • First-aid Treatment
        • Sports
        • Trophotherapy
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • 5% Dextrose Injection
        • 10% Dextrose Injection
        • 50% Dextrose Injection
        • 70% Dextrose Injection
        • Others
      • By Application:
        • First-aid Treatment
        • Sports
        • Trophotherapy
        • Others
      • By Distribution Channel:
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Pfizer Inc. *
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Amphastar Pharmaceuticals Inc.
    • Shangai Haixin group Co. Ltd.
    • Seqirus GmbH
    • Baxter International Inc.
    • Shandong Qidu Pharmaceutical
    • Sanctus drugs and pharmaceuticals Pvt.
    • Hospira Inc.
    • B Braun Medical Ltd.
    • Aurobindo Pharmaceuticals Ltd.
    • SteriMAx Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Highlights
    • Regulatory Scenario
    • PEST Analysis
    • Porter’s Analysis
    • Mergers and Acquisition
    • Product Launches/Approvals
  4. Global Dextrose Injection Market – Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Supply Chain Analysis
    • Government Measures to Combat COVID-19
  5. Global Dextrose Injection Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • 5% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • 10% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • 50% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • 70% Dextrose Injection
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Dextrose Injection Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • First-aid Treatment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Sports
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Trophotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Dextrose Injection Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Dextrose Injection Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Amphastar Pharmaceuticals Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Shangai Haixin group Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Seqirus GmbH
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Baxter International Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Shandong Qidu Pharmaceutical
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanctus Drugs and Pharmaceuticals Pvt.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • B Braun Medical Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Aurobindo Pharmaceuticals Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SteriMAx Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 36 market data tables and 35 figures on "Dextrose Injection Market” - Global Forecast to 2027

Frequently Asked Questions

The global dextrose injection market size is estimated to be valued at US$ 9,512.7 million in 2020 and is expected to exhibit a CAGR of 5.7% between 2020 and 2027.
Increasing incidence of diabetes and conditions associated with diabetes such as hypoglycemia, increasing launch and approval of products, and rising government initiatives for the promotion of sports among individuals suffering from disabilities are expected to drive the market growth over the forecast period.
5% dextrose injection is the leading product type segment in the dextrose injection market.
North America holds largest market share in the global dextrose injection market.
Side effects caused by dextrose injection such as fever, infection at the site of injection, and blood clot at the site of injection, and voluntary product recall are major factors restraining growth of the dextrose injection market.
Major players operating in the global dextrose injection market include Pfizer Inc., Amphastar Pharmaceuticals Inc., Shangai Haixin group Co. Ltd., Seqirus GmbH, Baxter International Inc., Shandong Qidu Pharmaceutical, Sanctus drugs and pharmaceuticals Pvt., Hospira Inc., B Braun Medical Ltd., Aurobindo Pharmaceuticals Ltd., and SteriMAx Inc.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner